Skip to main content
Explore URMC

UR Medicine

menu
UR Medicine / Neurology / Education and Training / Neurology Fellowships / Vascular Neurology Fellowship / Curriculum / Stroke Fellows Journal Club / Thrombolytic and Antithrombotic Therapy in Acute Ischemic Stroke

Thrombolytic and Antithrombotic Therapy in Acute Ischemic Stroke

Tissue Plasminogen Activator For Acute Ischemic Stroke

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke

Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study

Low Molecular Weight Heparinoid, ORG 10172 (Danaparoid), and Outcome After Acute Ischemic Stroke